CIK 0000727510
- Non-accelerated filer
- Smaller reporting company
Viskase Holdings, Inc.
Sign in to watch- Ticker
- VISK
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222372868
- Phone
- +1 630-874-0700
- Business address
- 333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
- Former names
- ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-04-03 | del Campo Ralph Chief Operating Officer | Option exercise | +12,600 | 163,222.14 | ||
| 2010-04-03 | del Campo Ralph Chief Operating Officer | Shares withheld for taxes | −4,463 | $10.48 | $47K | 158,759.14 |
| 2010-04-03 | del Campo Ralph Chief Operating Officer | Option exercise · Restricted Stock Units | −12,600 | 16,800 | ||
| 2010-04-03 | HORAK IVAN D President of R&D | Option exercise | +19,860 | 59,007 | ||
| 2010-04-03 | HORAK IVAN D President of R&D | Shares withheld for taxes | −7,035 | $10.48 | $74K | 51,972 |
| 2010-04-03 | HORAK IVAN D President of R&D | Option exercise · Restricted Stock Units | −19,860 | 26,480 | ||
| 2010-02-24 | TOOMAN CRAIG A Exec. VP Finance, CFO | Option exercise | +50,000 | $6.95 | $348K | 178,096 |
| 2010-02-24 | TOOMAN CRAIG A Exec. VP Finance, CFO | Option exercise | +50,000 | $5.73 | $287K | 228,096 |
| 2010-02-24 | TOOMAN CRAIG A Exec. VP Finance, CFO | Option exercise | +50,000 | $6.97 | $349K | 278,096 |
| 2010-02-24 | TOOMAN CRAIG A Exec. VP Finance, CFO | Sale | −150,000 | $9.27 | $1.4M | 128,096 |
| 2010-02-24 | TOOMAN CRAIG A Exec. VP Finance, CFO | Option exercise · Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2010-02-24 | TOOMAN CRAIG A Exec. VP Finance, CFO | Option exercise · Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2010-02-24 | TOOMAN CRAIG A Exec. VP Finance, CFO | Option exercise · Stock Option (Right to Buy) | −50,000 | 0 | ||
| 2010-02-22 | HORAK IVAN D EVP, R&D, CSO | Sale | −200 | $9.34 | $2K | 140,276 |
| 2010-02-22 | HORAK IVAN D EVP, R&D, CSO | Sale | −100 | $9.33 | $933 | 140,176 |
| 2010-02-22 | HORAK IVAN D EVP, R&D, CSO | Sale | −4,406 | $9.33 | $41K | 135,770 |
| 2010-02-22 | HORAK IVAN D EVP, R&D, CSO | Sale | −300 | $9.32 | $3K | 135,470 |
| 2010-02-22 | HORAK IVAN D EVP, R&D, CSO | Sale | −1,600 | $9.32 | $15K | 133,870 |
| 2010-02-22 | HORAK IVAN D EVP, R&D, CSO | Sale | −100 | $9.31 | $931 | 133,770 |
| 2010-02-22 | HORAK IVAN D EVP, R&D, CSO | Sale | −8,720 | $9.30 | $81K | 125,050 |
Page 14 of 25 · 488 trades